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Summary
The polarization of a neuron generally results in the
formation of one axon andmultiple dendrites, allowing
for the establishment of neuronal circuitry. Themolec-
ular mechanisms involved in priming one neurite to
become the axon, particularly those regulating the mi-
crotubule network, remain elusive. Here we report the
identification of DOCK7, amember of the DOCK180-re-
lated protein superfamily, as a Rac GTPase activator
that is asymmetrically distributed in unpolarized
hippocampal neurons and selectively expressed in
the axon. Knockdown of DOCK7 expression prevents
axon formation, whereas overexpression induces for-
mation of multiple axons. We further demonstrate that
DOCK7 and Rac activation lead to phosphorylation
and inactivation of the microtubule destabilizing pro-
tein stathmin/Op18 in the nascent axon and that this
event is important for axon development. Our findings
unveil a pathway linking the Rac activator DOCK7 to
a microtubule regulatory protein and highlight the
contribution of microtubule network regulation to
axon development.
Introduction
Neurons are one of the most highly polarized cell types
in nature. Typically, they polarize to elaborate one long
axon and multiple, shorter dendrites so as to transmit
and receive information and form circuitry (Craig and
Banker, 1994). How a neuron acquires and maintains
its axon-dendrite polarity are enduring questions under
intense investigation. A model system widely used for
studying neuronal polarization is the primary culture of
dissociated hippocampal neurons from rodents (Banker
and Goslin, 1998). These neurons polarize gradually in
successive steps. Shortly after plating, a neuron at-
taches to the substratum and forms lamellipodia (stage
1), from which several minor neurites sprout (stage 2).
After 24 hr, only one of these neurites elongates rapidly
to form the axon (stage 3), whereas several days later the
remaining neurites grow to form the dendrites (stage 4).
In general, a neuron is considered polarized when the
axon is distinct from the dendrites both in length and
in composition of molecular markers. Significantly, re-
cent in vivo studies and time-lapse analysis of living
brain slices have revealed that developing hippocampal
and cortical neurons undergo similar morphological
*Correspondence: vanaelst@cshl.educhanges during migration before becoming polarized,
with ‘‘multipolar’’ cells extending several minor neurites
during an intermediate stage (Nakahira and Yuasa, 2005;
Noctor et al., 2004).
The mechanisms underlying neuronal polarization are
complex and involve integration of signals or cues that
determine which neurite is to become the axon and
that promote rapid neurite elongation and sustain axo-
nal outgrowth. A number of studies proposed that en-
hancement of neurite elongation directs axon specifica-
tion, since manipulations of neurite length can reset
neurite competition, and exposure of a neurite to extra-
cellular adhesion molecules, such as laminin, favors
axon formation (Esch et al., 1999; Lamoureux et al.,
2002). A recent study, however, suggests that centro-
some localization in the early postmitotic stage instructs
where the axon will form and that axonal fate is deter-
mined entirely within the neuron (de Anda et al., 2005).
Notwithstanding, preferential localization or activation
of the growth-promoting machinery in just one neurite
of an unpolarized neuron is key in priming this neurite
to become the axon. Intracellular mechanisms that en-
hance neurite/axon growth involve changes in both ac-
tin and microtubule (MT) networks. For instance, actin
instability is highest in the neurite destined to become
the axon, and locally destabilizing actin filaments can in-
duce axon formation (Bradke and Dotti, 1999; Da Silva
et al., 2005). There is also a dramatic influx of MTs into
the nascent axon that together with enhanced MT
growth is believed to contribute to neurite/axon elonga-
tion (Baas, 2002; Yu and Baas, 1994; Yu et al., 2001).
Several molecules linked to the regulation of the cyto-
skeleton have been implicated in different steps of
neuronal polarization. When perturbing their functions,
either longer, multiple, or no axons are formed, or the
neurites lack axonal or dendritic qualities (reviewed in
Arimura and Kaibuchi, 2005; Wiggin et al., 2005). These
molecules include the evolutionarily conserved Par3/
Par6/aPKC complex, the Akt/GSK-3b/CRMP-2 or APC
complex, SAD kinases, Ras and Rho family members,
and the membrane enzyme PMGS, which influences
the activities of Rac and Rho GTPases (Da Silva et al.,
2005; Jiang et al., 2005; Kishi et al., 2005; Nishimura
et al., 2005; Schwamborn and Puschel, 2004; Shi et al.,
2003, 2004; Yoshimura et al., 2005). Yet, asymmetric
molecular localization in unpolarized stage 2 neurons
has only been reported for PMGS, kinesin-1, Rap1b,
and Rho family members, not for the other molecules
or their associated activities (Da Silva et al., 2005; Ja-
cobson et al., 2006; Schwamborn and Puschel, 2004).
Evidence has been provided that suggests that local-
ized activation of Rac and concomitant inactivation of
RhoA GTPases within one neurite of an unpolarized neu-
ron contribute to axon formation by inducing actin insta-
bility (Da Silva et al., 2005). Of interest is that Rac, be-
sides controlling the actin cytoskeleton, also regulates
MT dynamics in nonneuronal cells. In particular, Rac
promotes MT growth into the advancing lamellipodia
of migrating cells (Wittmann et al., 2003). This raises
the question whether a distinctive Rac-mediated
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thereby contributing to its elongation. Thus far, little is
known about the regulation of MT growth in the neurite
destined to become the axon.
Here we report the identification of DOCK7, a previ-
ously uncharacterized member of the DOCK180-related
protein superfamily, as an activator of Rac GTPases that
is highly expressed in the developing brain. We demon-
strate that DOCK7 is asymmetrically distributed in stage
2 hippocampal neurons and provide evidence that this
protein plays a critical role in axon formation through
Rac activation. We further show that DOCK7 mediates
laminin-induced phosphorylation of the MT-destabiliz-
ing protein stathmin/Op18 and that the latter is impor-
tant for the development of the axon. Our data delineate
a pathway linking the Rac activator DOCK7 to a MT
regulatory protein and support the idea that spatially
controlled regulation of MT networks is important for
axon formation and neuronal polarization.
Results
Identification of DOCK7 as an Activator
of Rac GTPases
To search for upstream regulators of Rac GTPases in-
volved in neuronal development, the yeast two-hybrid
(YTH) approach was used to screen a human fetal brain
cDNA library with the dominant-negative mutant form of
Rac1 (Rac1N17) as bait. One of the positive clones
contained a cDNA matching a C-terminally located se-
quence in the KIAA1771 clone (AB051558). The latter en-
codes a C-terminal fragment of DOCK7, a member of the
DOCK180-related superfamily of proteins (also referred
to as CZH proteins), which have emerged as novel acti-
vators of the Rho GTPases. This family contains at least
11 mammalian proteins, DOCK1 (=DOCK180)-DOCK11,
and has members in many other eukaryotes (Cote and
Vuori, 2002; Meller et al., 2005). The YTH clone, referred
to as DOCK7-C, showed strong binding to wild-type (wt)
and dominant-negative mutant forms of Rac1 and the
highly brain enriched Rac isoform Rac3, but only weak
or no binding to the constitutively activated mutant
forms of Rac1 and Rac3, respectively (Figure 1A). No
interaction was detected with wt or any of the mutant
forms of Cdc42 or RhoA (data not shown).
The full-length DOCK7 cDNA clone was isolated (see
Experimental Procedures) and contains an ORF of
6390 bp that encodes a protein with a predicted molec-
ular mass of 241 kDa. BLAST searches and Pfam analy-
sis with the full-length DOCK7 polypeptide sequence in-
dicated that it is most homologous to the mammalian
DOCK6 and DOCK8 family members and revealed two
domains that are highly conserved throughout the
DOCK180 superfamily: the catalytic DHR-2 domain
(also termed Docker or CZH2 domain) and the DHR-1
(CZH1) domain (Figure 1B) (Brugnera et al., 2002; Cote
and Vuori, 2002; Meller et al., 2005). In contrast to the ca-
nonical Rho guanine nucleotide exchange factors (Rho-
GEFs), the DOCK180 family members do not contain the
hallmark catalytic domain (Dbl homology-pleckstrin
homology domain) that carries out the GEF activity. In-
stead, the DHR-2 domain of several DOCK180 family
members has been shown to mediate the GDP-GTP ex-
change reaction of Rho proteins (Cote and Vuori, 2002;Meller et al., 2005). A recent study indicated that the
DHR-1 domain of DOCK180 binds PtdIns(3,4,5)P3
(Cote et al., 2005). No other recognizable motifs in
DOCK7 were identified.
To determine whether full-length DOCK7 interacts
with Rac proteins and whether this interaction is nucle-
otide dependent, lysates from N1E-115 neuroblastoma
cells were incubated with GTPgS-loaded, GDPbS-
loaded, or nucleotide-free Rac1- or Rac3-GST fusion
proteins immobilized on glutathione beads, and the
bound proteins were analyzed by Western blotting using
anti-DOCK7 polyclonal antibody. We found that DOCK7
associates with nucleotide-free, but not GDPbS or
GTPgS-loaded, Rac1 and Rac3 proteins. No interaction
was detected between DOCK7 and Cdc42 or RhoA pro-
teins (Figure 1C). The association between nucleotide-
free Rac proteins and DOCK7 also occurs in cells, as ob-
served by immunoprecipitation studies of HEK293 cells
expressing Flag-tagged DOCK7 and Myc-tagged Rac1
or Rac3 (Figure 1D and data not shown).
The finding that DOCK7 specifically associates with
nucleotide-free Rac proteins suggested a role for
DOCK7 as an activator of Rac GTPases. To demonstrate
that DOCK7 induces GTP loading of Rac in cells, we per-
formed ‘‘PBD pull-down assays.’’ The premise of this as-
say is that the p21 Rac/Cdc42 binding domain (PBD) of
PAK only binds to the active GTP-bound form of Rac.
HEK293 cells were cotransfected with Myc-tagged
Rac1 and full-length DOCK7, a C-terminal fragment of
DOCK7 containing the DHR-2 domain (DOCK7-C, see
Figure 1B), or an empty control vector. Rac1-GTP was
precipitated from cell lysates using the PBD of PAK1
fused to GST. We found that overexpression of DOCK7
or DOCK7-C significantly increases GTP loading of
Rac1 compared to empty vector (Figure 1E). A DOCK7
deletion mutant (DOCK7DDHR-2) that lacks the DHR-2
domain and is defective in Rac1 binding failed to
activate Rac1 in this assay (see Figure S1 in the Supple-
mental Data available online). Similarly, when Rac3
was coexpressed with full-length DOCK7 or DOCK7-C,
we observed a 2.0- and 2.85-fold increase in GTP-
bound Rac3, respectively, whereas coexpressing
DOCK7DDHR-2 had no effect. No increase in GTP-bound
Cdc42 was detected when Cdc42 was coexpressed
with either DOCK7 or DOCK7-C (data not shown).
Additional evidence that DOCK7 activates Rac pro-
teins was provided by GDP release assays. Recombi-
nant Rac1, Cdc42, and RhoA proteins fused to GST
were loaded with [3H] GDP and incubated with extracts
from HEK293T cells expressing DOCK7-C, DOCK180-
DHR-2 as a positive control, or an empty control vector.
We observed that the GDP release rate from Rac1, but
not from Cdc42 or RhoA, increased in the presence of
DOCK7-C and DOCK180-DHR-2 containing extracts
when compared to control vector extracts (Figure 1F).
Taken together, our findings strongly suggest that
DOCK7 is a GEF for Rac GTPases and that its DHR-2
domain likely carries out the GEF activity.
DOCK7 Is Highly Expressed in the Brain during
Early Stages of Development
Among the identified DOCK180 family members,
DOCK180 and DOCK2 have been studied most exten-
sively. The ubiquitously expressed DOCK180 protein
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729Figure 1. DOCK7 Associates with and Activates Rac
(A) YTH interactions between Rac and DOCK7-C. The L40 yeast strain was transformed with plasmids expressing DOCK7-C fused to the GAL4
activation domain (GAD), and the indicated Rac mutants, or Lamin control, fused to the LexA DNA-binding domain (LBD) and tested for growth on
medium lacking histidine.
(B) Schematic representations of DOCK7 and DOCK7-C.
(C) Selective binding of DOCK7 to nucleotide-free Rac, but not Cdc42 or RhoA. GTPgS-loaded (GTP), GDPbS-loaded (GDP), or nucleotide-free
(2) Rac1, Rac3, Cdc42, and RhoA-GST fusion proteins were incubated with extracts from N1E-115 cells. Bound DOCK7 was detected by immu-
noblotting with anti-DOCK7 antibody (Ab). Input lane shows 1/15 of the amount of extract used for the assay. Purified GST-Rac1, Rac3, Cdc42, or
RhoA fusion proteins were detected by Coomassie blue staining.
(D) DOCK7 associates with Rac in mammalian cells. HEK293 cells were transfected with the indicated plasmids. Cell extracts containing 5 mM
EDTA were immunoprecipitated (IP) with anti-Flag antibody and analyzed by Western blotting (WB) with anti-Flag and anti-Myc antibodies.
(E and F) Activation of Rac by DOCK7 measured with (E) PBD pull-down assays and (F) GDP release assays. (E) HEK293 cells were transfected
with the indicated plasmids, and GTP-bound Rac1 was precipitated from detergent extracts with GST-PBD. GST-PBD-bound Myc-Rac1-GTP
and total Myc-Rac1 in cell lysates were detected by immunoblotting with anti-Myc antibody and quantified by direct imaging of chemilumines-
cent signals. DOCK180 wt was included as a positive control. The relative amount of Myc-Rac1-GTP in extracts (compared to vector control) is
indicated in the bottom panel. (F) [3H] GDP-loaded Rac1, Cdc42, and RhoA were incubated with extracts from HEK293T cells expressing DOCK7-
C, DOCK180-DHR-2, or empty vector. At the indicated time points, the amount of [3H] GDP bound to the GTPases was measured using a filter-
binding assay, and the results were presented relative to the 0 time point, which was defined as 1. Values are means of triplicate samples6 SD.
Similar results were obtained in two other experiments.and its orthologs in Drosophila and C. elegans play cru-
cial roles as upstream activators of Rac in actin cyto-
skeletal remodeling, cell migration, and phagocytosis
(Gumienny et al., 2001; Kiyokawa et al., 1998; Nolan
et al., 1998; Wu and Horvitz, 1998). DOCK2, which is pre-
dominantly expressed in lymphocytes, plays a key role
as a Rac activator in lymphocyte homing to lymphoid tis-
sues (Fukui et al., 2001). To date, however, nothing is
known about the function of DOCK7, and the biological
roles of its closest related family members, DOCK6 and
DOCK8, are also largely unknown. We began the char-
acterization of DOCK7 by determining its presence
and distribution in the brain. Immunoblot experiments
of postnatal day 5 (P5) rat tissues showed that DOCK7
protein levels were highest in the brain but were also de-
tectable to variable extents in other tissues (Figure 2A).DOCK7 was present in all major regions of P5 rat brain
examined (Figure 2B). Furthermore, virtually all neuronal
populations, including neurons of the hippocampus,
stained positive for DOCK7 (Figure 2G). Interestingly,
DOCK7 protein levels in the brain were higher at late em-
bryonic and early postnatal days and then decreased
gradually, but markedly, into adulthood (Figure 2C).
Analysis using extracts from primary hippocampal cul-
tures showed highest levels of DOCK7 protein 1 day
after plating, when axons begin to emerge, and then
a gradual decline at later stages (Figure 2D), suggesting
a potential role for DOCK7 in axon development and
neuronal polarization. In contrast, when we examined
the protein levels of DOCK180 in hippocampal neurons,
we observed low levels at early stages, which increased
moderately at later stages (Figure 2E), questioning
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730Figure 2. DOCK7 Is Highly Expressed in the
Developing Brain
(A) Multiple-tissue Western blot from a post-
natal day 5 (P5) rat probed with anti-DOCK7
antibody. B, brain; SM, skeletal muscle; H,
heart; Li, liver; Lu, lung; K, kidney; S, spleen.
(B) DOCK7 immunoblot of P5 rat brain re-
gions. Ce, cerebellum; Hi, hippocampus; Th,
thalamus; Co, sensory cortex; Fl, frontal
lobes; Olf, olfactory bulb.
(C) DOCK7 immunoblot of embryonic day 18
(E18), P2, P6, P10, P30, and adult (>8 weeks
old) rat brains.
(D–F) Immunoblots of rat hippocampal neu-
rons cultured in vitro for 6 hr, 1 day, 2 days,
3 days, 7 days, and 21 days probed with
anti-DOCK7 antibody (D), anti-DOCK180
antibody (E), or anti-oligophrenin-1 as a load-
ing control (F).
(G) Parasagittal brain section through the hippocampus from a P2 rat was double-immunolabeled with anti-DOCK7 antibody (green) and an
antibody against NeuN, which predominantly labels nuclei (red). Scale bar, 100 mm. Lower panel shows an enlarged view of the boxed area in
the upper panel. Scale bar, 20 mm.a prominent role for DOCK180 in axon development. No-
tably, RT-PCR and Northern blot analysis showed that
DOCK6 and DOCK8 are only expressed at very low
levels in the brain (Ruusala and Aspenstrom, 2004, and
data not shown).
Polarized Distribution of DOCK7
in Hippocampal Neurons
To assess a role for DOCK7 in neuronal polarity, we be-
gan by examining the localization of DOCK7 in hippo-
campal neurons during early stages of development.
E18 rat hippocampal neurons were isolated, cultured
on laminin, and stained with anti-DOCK7 antibody and
phalloidin or one of the indicated antibodies at stages
1, 2, and 3 of neuronal development (Figure 3A). In stage
1 neurons, DOCK7 immunofluorescence was present
throughout the cell body, but not in the actin-rich lamel-
lipodial veil and filopodial extensions that surround the
cell body, as judged by costaining with phalloidin (bot-
tom panel, left). Noticeably, strong staining of DOCK7
around the cell periphery was observed (Figure 3A),
which was most prominent on the basal side of the cell
where the cell attaches the substrate (data not shown).
In stage 2 neurons, DOCK7 was detected in the cell
body and the multiple undifferentiated minor processes
(neurites), which were visualized with the microtubule
marker a-tubulin (Figure 3A, top panel, left). Interest-
ingly, we observed more prominent DOCK7 staining in
only one of the multiple neurites for a significant number
of unpolarized stage 2 neurons (Figure 3A, arrows)
(41.7%6 6.1%, n = 46 versus 4.0%6 2.8%, n = 50 using
a control antibody; p < 0.02, c2 test; the percentages
represent stage 2 neurons that have in one neurite
>1.5 times the fluorescence intensity of DOCK7 or con-
trol antibody than in any of the other neurites after nor-
malization to the fluorescence intensity of a cytoplasmic
volume marker; see Supplemental Data). To determine
whether this neurite is the one that will become the
axon, we analyzed the content of polymerized actin in
the same cell. Previous studies have established that
the neurite with the lowest actin filament content in its
growth cone becomes the axon (Da Silva et al., 2005).
We found the highest levels of DOCK7 expression inthe neurite with the lowest actin filament content (Fig-
ures 3B and 3C). In polarized stage 3 neurons, we noted
that DOCK7 was expressed abundantly in the longest
neurite, which stained positive for Tau-1 (the axon),
but was barely detectable in minor neurites that were la-
beled positive for MAP2 (Figure 3A, right panel). No co-
localization of DOCK7 with actin was observed at the
periphery of the axonal growth cone; however, strong
DOCK7 staining was noted in the shaft of the axon and
in the proximal region of the growth cone where MTs
are concentrated (Figures 3A and 3D). In contrast to
DOCK7, we found that DOCK180 was uniformly distrib-
uted in the axon and the smaller processes in stage 3
neurons (data not shown). Thus far, only a few molecules
have been reported to asymmetrically accumulate in
a single neurite of unpolarized stage 2 neurons, with lo-
calization generally restricted to the tip of the neurite (Da
Silva et al., 2005; Jacobson et al., 2006; Schwamborn
and Puschel, 2004). Our data show that DOCK7 is pref-
erentially expressed in the shaft and proximal region of
the growth cone of one of the stage 2 neurites and that
the polarized distribution of DOCK7 correlates with the
formation of the axon. These results suggest a role for
DOCK7 in the rapid elongation of the nascent axon.
DOCK7 Overexpression Induces the Formation
of Multiple Axons
To test whether DOCK7 is important for axon formation,
embryonic neurons in suspension were cotransfected
with a GFP expression plasmid and a T7-tagged
DOCK7 construct or a control vector. Approximately
45–52 hr after plating on coverslips coated with poly-
L-lysine and laminin, the transfected neurons were
stained with anti-Tau-1 and anti-MAP2 antibodies, and
polarity was assessed for GFP-positive cells. We con-
firmed that all GFP-positive cells stained positive for
the T7 epitope. In all of our experiments, an axon was
defined as a long process (>70 mm in length) that ex-
presses the axonal marker Tau-1, but not the dendritic
marker MAP2. Cells with one long axon and multiple
minor neurites were considered polarized neurons.
The control vector transfected neurons displayed
normal polarity, with most of them having a single
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tiple minor processes that were rich in MAP2 (Figures
4A–4C). In contrast, a large number of neurons express-
ing T7-tagged DOCK7 exhibited abnormal polarity. In-
stead of one single axon, they contained multiple axons
that were >70 mm in length and enriched in Tau-1, but not
in MAP2 (Figures 4A–4C). All of these processes also
stained positive for DOCK7. Expression of DOCK7 did
not affect the total number of processes formed per
cell compared to vector control transfected neurons
(Figure 4D), indicating the formation of axons at the
expense of dendrites. Thus, our data show that DOCK7
induces the formation of multiple axons and perturbs
neuronal polarization. Notably, when culturing the
DOCK7-expressing neurons until day 6, we observed
that all axons were still enriched in Tau-1 (Figure S2).
We next tested the effects of coexpressing a domi-
nant-negative mutant form of Rac3 (Rac3N17) or Rac1
(Rac1N17) with DOCK7 on the formation of multiple
axons. We found that both Rac3N17 and Rac1N17 in-
hibit axon formation and interfere with the formation of
multiple axons of DOCK7-expressing cells (Figures
4E–4G and data not shown). The majority of cells coex-
pressing DOCK7 and one of the dominant-negative
Rac mutants exhibited minor neurites of similar length,
but no axon. Furthermore, we found that expression of
the DOCK7DDHR-2 mutant, which is defective in Rac
binding and activation (Figure S1), does not induce
the formation of multiple axons (Figures 4E–4G). Inter-
estingly, about 40% of these neurons displayed one
axon, whereas more than 50% showed no axon. These
data suggest that DOCK7DDHR-2 functions as a domi-
nant-negative mutant. Our findings described above,
together with our biochemical data, imply that DOCK7
promotes axon formation by acting on Rac GTPases.
DOCK7 Is Required for Axon Formation
To assess whether DOCK7 is required for neuronal po-
larization, we tested the effects of DOCK7 knockdown
on axon formation using RNA interference (RNAi). Two
hairpin-forming sequences were designed, one target-
ing the DOCK7 protein coding sequence (Dock7#1)
and the other the 30 untranslated region (Dock7#2) of
the mouse/rat DOCK7 mRNA, and the resulting oligonu-
cleotides were cloned into the pSUPER vector (see Sup-
plemental Data). Expression of either the Dock7#1 or
Dock7#2 hairpin (hp) construct, but not a control hp con-
struct, dramatically reduced DOCK7 levels in hippocam-
pal neurons (Figure 5B and Figure S3). The effect of
DOCK7 knockdown on neuronal polarity was then as-
sessed as described above. Most of the neurons trans-
fected with the control hp construct displayed normal
polarity, with one long axon and several minor pro-
cesses (Figures 5A and 5C). In contrast, a significant
number of neurons transfected with either pSUPER-
Dock7#1 or pSUPER-Dock7#2 lacked a long Tau-
1-positive axon but instead displayed multiple small
processes (Figure 5A). The percentage of polarized
Dock7#1 and Dock7#2 hp-expressing neurons was sig-
nificantly lower compared to that of control hp-express-
ing neurons (Figure 5C). Expression of the Dock7 hp
constructs did not affect the total number of processes
formed per cell (Figure 5D) or the length of the minor
neurites (Figure 5E). We next determined whether rein-troduction of DOCK7 could rescue the loss of axon for-
mation phenotype in neurons with reduced DOCK7
expression. To this end, we coexpressed full-length
DOCK7 and the Dock7#2 hp construct that targets the
30 UTR. We observed that the levels of DOCK7 in neu-
rons coexpressing DOCK7 and Dock7#2 hp were nearly
similar to those of endogenous DOCK7 in control cells
(Figure S3). Most importantly, we found that the majority
of these neurons displayed normal polarity, with a single
long axon and multiple minor processes (Figures 5F and
5G). Together, our data indicate that DOCK7 is required
for axon formation and neuronal polarization.
DOCK7 Regulates Stathmin/Op18 Phosphorylation
in Developing Neurons
What is the mechanism by which DOCK7 contributes to
axon formation? We found no evidence to suggest that
DOCK7 plays a prominent role in the regulation of the
actin cytoskeleton. For instance, we did not observe co-
localization of DOCK7 with actin at the periphery of the
axon’s growth cone. Moreover, in contrast to the Rac-
GEF Tiam1/STEF (Nishimura et al., 2005), DOCK7 stain-
ing was not observed in the lamellipodia of PDGF-
treated NIH 3T3 cells, nor was lamellipodia formation
seen in these cells upon DOCK7 expression (data not
shown). However, in addition to its well-established
role in actin remodeling, Rac has been shown to promote
MT growth into advancing lamellipodia of migrating PtK1
epithelial cells (Wittmann et al., 2003). Recent studies
support the idea that Rac regulates leading-edge MT dy-
namics by locally enhancing stathmin/Op18 (Op18)
phosphorylation at serine 16, thereby inactivating its
MT-destabilizing activity (Daub et al., 2001; Wittmann
et al., 2004). Op18 is a ubiquitous phosphoprotein with
tubulin-binding and MT-destabilizing activities, and it
participates in the regulation of MT dynamics in vivo (Bel-
mont and Mitchison, 1996; Curmi et al., 1999). Like
DOCK7, Op18 is highly expressed in developing neurons,
including the hippocampus, and is strongly downregu-
lated after synapse formation (Shumyatsky et al., 2005).
These findings led us to investigate whether DOCK7 is
involved in the regulation of Op18-S16 phosphorylation
in developing hippocampal neurons and whether this
event is important for axon formation. The amounts of
phosphorylated Op18-S16 (Op18-S16-P) in neurons
plated on poly-L-lysine-coated dishes layered with or
without laminin were first determined by Western blot
analysis with an antibody specific for the phosphory-
lated serine 16 form of Op18 (Gavet et al., 1998). We
found that the levels of Op18-S16-P were significantly
higher when neurons were plated on laminin-coated
dishes (Figure 6A). This is of interest given that laminin
is known to promote axonal elongation and to trigger ac-
tivation of Rac in several cell types (Esch et al., 1999; Gu
et al., 2001). We then examined whether DOCK7 knock-
down and overexpression affects the levels of Op18-
S16-P in neurons plated on laminin-coated dishes. The
lentiviral vector pTRIPDU3-EF1a-EGFP (pTRIP) was
used to deliver Dock7#1 and Dock7#2 hp RNA ex-
pression cassettes into hippocampal neurons at high
efficiency (Janas et al., 2006). Expression of Dock7#1
or Dock7#2 hp RNA, but not a control hp RNA, drasti-
cally reduced the levels of DOCK7 protein and,
more importantly, diminished significantly the levels of
Neuron
732Figure 3. Polarized Distribution of DOCK7 in Hippocampal Neurons
(A) Neurons at stages 1, 2, and 3 of development were costained with anti-DOCK7 (green) and anti-a-tubulin, phalloidin, anti-Tau-1, or anti-MAP2
(red) antibodies. Arrowheads indicate enrichment of DOCK7 in a single neurite of unpolarized stage 2 neurons. Scale bar, 20 mm.
(B and C) High levels of DOCK7 expression correlate with localized reduction of F-actin staining in a single neurite of a stage 2 neuron. (B) Left
panel shows a stage 2 neuron (from panel [A]) double-immunostained with anti-DOCK7 antibody (green) and phalloidin (red). The right panels
show the profiles of DOCK7 and actin fluorescence intensities in each of the numbered processes of the depicted stage 2 neuron (from the prox-
imal to the distal end of the processes). The data shown is representative of more than 40 stage 2 neurons. (C) DOCK7 and actin fluorescence
intensities at a region of interest (ROI) at the distal end of each neurite shaft and at the tip of each neurite, respectively, were quantitated for
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duces the Formation of Multiple Axons
through Rac Activation
(A) Neurons coexpressing GFP and T7-
DOCK7, or a control vector, were plated on
laminin-coated coverslips and stained 45–52
hr later with anti-Tau-1 (blue) and anti-MAP2
(red) antibodies. Scale bar, 20 mm.
(B) Length of axons/neurites from DOCK7
and vector control expressing neurons after
culturing them for 45–52 hr (n = 30 for each
condition). The x axis indicates rank order of
the processes by length, from long to short.
Error bars indicate SD.
(C) Percentage of polarized neurons is
shown. DOCK7 overexpression induces po-
larity defects (*p < 0.005, c2 test; n = 140 neu-
rons for control vector and 139 for DOCK7).
(D) Quantification of the number of processes
per cell. DOCK7 does not alter the total num-
ber of processes formed per cell (p = 0.48, t
test; n = 140 neurons for control vector and
139 for DOCK7).
(E) Representative images of neurons co-
transfected with vector expressing GFP and
empty control vector, T7-DOCK7, Myc-
Rac3N17, or a combination of T7-DOCK7
and Myc-Rac3N17 (left), and GFP and T7-
DOCK7DDHR-2 (right). Overlay of GFP
(green) and Tau-1 (red) staining is shown.
Rac3N17 prevents the induction of multiple
axons triggered by ectopic expression of
DOCK7 (left panel). DOCK7DDHR-2 fails to in-
duce multiple axons; either one or no axon is
formed (right panel). GFP-positive cells were
also tested for Myc- and/or T7-tag immuno-
reactivity (data not shown). Scale bar, 20 mm.
(F) Percentage of neurons with more that one
axon is shown. Only cells expressing T7-
DOCK7 have multiple axons (*p < 0.005, c2
test; n = 50 neurons for each condition).
(G) Quantification of the number of processes
per cell. Expression of T7-DOCK7, T7-
DOCK7DDHR-2, or Myc-Rac3N17 does not
alter the total number of processes per cell
(p > 0.5, t test, n = 50 neurons for each condi-
tion). Similar results were obtained for
Rac1N17 (data not shown).
Error bars in (C), (D), (F), and (G) indicate SEM.Op18-S16-P (Figures 6B and 6C). The steady-state
levels of Op18 protein in lysates from neurons express-
ing Dock7 hp RNAs and control hp RNA were essentially
identical (Figure 6B). Similarly, we found that interfering
with Rac function also decreased the levels of Op18-
S16-P in hippocampal neurons (data not shown). Fur-
thermore, we observed that ectopic expression of
DOCK7, but not DOCK7DDHR-2, increased the levels
of Op18-S16-P (Figure 6D and 6E). Thus, our data indi-
cate that DOCK7, as an activator of Rac, is required for
laminin-induced Op18-S16 phosphorylation in develop-
ing neurons.
We next assessed whether regulation of Op18-S16
phosphorylation is important for axon formation. To
this end, we quantified the levels of Op18-S16-P in the
developing axon and the future dendrites and examinedthe effects of ectopic expression of wt Op18 and an
Op18-S16 phosphorylation-deficient mutant (Op18-
S16A) on axon development. If S16 phosphorylation
and concomitant inactivation of the MT-destabilizing
activity of Op18 is important for axon formation, one
would expect higher levels of Op18-S16 phosphoryla-
tion in the developing axon than in the future dendrites.
Forty-five to sixty hours after plating E18 hippocampal
neurons on laminin-coated coverslips, the fluorescence
intensities of Op18-S16-P and total Op18 (relative to a
cytoplasmic marker, CellTracker Green CMFDA) were
measured proximally to the distal ends of the axons
and the future dendrites (Figure 7A). We observed that
in 82.5% of the neurons examined, the levels of Op18-
S16-P were significantly higher in the developing axons
than those in the future dendrites (p = 0.00004, sign test;42 neurons. The mean fluorescence intensity of DOCK7 in neurites with lowest actin staining (left), and of actin in neurites with highest DOCK7
staining (right), versus all other neurites is shown (*p < 0.005, t test). AU, arbitrary unit. Error bars indicate SEM.
(D) Distribution of DOCK7, MTs, and F-actin in the growth cone of stage 3 hippocampal neurons, visualized with antibodies specific for DOCK7,
a-tubulin, and by phalloidin staining, respectively. Scale bar, 10 mm.
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Axon Formation
(A) Neurons were cotransfected with plas-
mids expressing GFP and Dock7#2 hairpin
(hp), or a scrambled (control) hp. GFP (green)
and Tau-1 (red) stainings are shown. Scale
bar, 20 mm.
(B) DOCK7 expression levels in neurons
transfected with empty vector or the indi-
cated hp RNA constructs were detected
with anti-DOCK7 antibody. Erk2 was used
as a loading control.
(C) Percentage of polarized neurons is
shown. Dock7#1 hp and Dock7#2 hp, but
not the control hp, perturb neuronal polarity
(*p < 0.001 for both Dock7 hp constructs
compared to vector, whereas p = 0.27 for
control hp compared to vector, c2 test; n =
133 neurons for vector, 153 for control hp,
183 for Dock7#1 hp, and 123 for Dock7#2 hp).
(D and E) Quantification of the number of pro-
cesses per cell (D) and the total length of mi-
nor neurites per cell (E). DOCK7 knockdown
does not affect the length of minor neurites
or the total number of processes (p > 0.4 for
all hp constructs when compared to empty
vector, t test; n = 133 neurons for vector,
152 for control hp, 183 for Dock7#1 hp, 123
for Dock7#2 hp).
(F and G) DOCK7 expression rescues the loss
of axon phenotype in Dock7#2 hp-expressing
neurons. (F) Neurons were cotransfected with
combinations of vectors expressing GFP,
control hp, Dock7#2 hp, and T7-DOCK7.
Overlay of GFP (green) and Tau-1 (red) stain-
ing is shown. Scale bar, 20 mm. (G) Percent-
age of polarized neurons is shown. The per-
centage of neurons with normal polarity is
restored upon coexpression of DOCK7 with
Dock7#2 hp (plasmid concentration: 2 to 1)
(*p < 0.001 between control hp + vector and Dock7#2 hp + vector, whereas p = 0.3 between control hp + vector and Dock7#2 hp + DOCK7,
c2 test; n = 55 neurons for control hp, 64 for Dock7#2 hp, and 70 for Dock7#2 hp + DOCK7).
Error bars indicate SEM for (C)–(E) and (G).n = 40; see Supplemental Data). However, no difference
was observed for the intensities of total Op18 staining
between the axons and the future dendrites (p = 0.1;
n = 40) (see also Figure S4).The effects of Op18 and Op18-S16A expression on
neuronal polarity were examined as described for
DOCK7. Notably, ectopic expression of wt stathmin/
Op18 molecules does not disrupt MTs in neuronal cells,Figure 6. DOCK7 Mediates Laminin-Induced
Op18-S16 Phosphorylation
(A) Detergent extracts from hippocampal
neurons cultured for 45–60 hr in dishes
coated with or without laminin were probed
with anti-Op18-S16-P antibody and anti-
Op18 Ab.
(B and C) DOCK7 knockdown reduces Op18-
S16 phosphorylation. (B) Neurons plated on
laminin were transduced with pTRIP lentiviral
vectors expressing Dock7#1, Dock7#2, con-
trol, or no (vector) hp RNA. Detergent extracts
were probed with anti-DOCK7, anti-Op18-
S16-P, anti-Op18, and anti-Erk2 Abs. (C)
Fold decrease in Op18-S16-P levels. The
data were normalized to total Op18 levels
and then to a value of 1.0 for control hp
(*p < 0.03 for Dock7#1 or Dock7#2 hp com-
pared to control hp, t test; n = 3).
(D and E) DOCK7 overexpression increases Op18-S16 phosphorylation. (D) Neurons plated on laminin were infected with recombinant adeno-
viruses expressing GFP (vector), T7-DOCK7 or T7-DOCK7DDHR-2. Blots were probed with anti-Op18-S16-P, anti-Op18, anti-b-tubulin, and anti-
T7 antibodies. (E) Fold increase in Op18-S16-P levels. The data were normalized to total Op18 levels and then to a value of 1.0 for the control virus
(*p < 0.03 for DOCK7 compared to control, t test; n = 3).
Error bars indicate SEM.
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735Figure 7. Op18-S16 Phosphorylation Is Im-
portant for Axon Formation
(A) Higher levels of Op18-S16-P are present in
axons than in future dendrites. Stage 3 neu-
rons plated on laminin were incubated with
Cell Tracker Green CMFDA (lower panel)
and then immunostained with anti-Op18-
S16-P antibody or Op18 antibody. Scale
bar, 20 mm. The histograms show the profiles
of Op18-S16-P (left) and Op18 (right) immu-
nofluorescence intensities in each of the
numbered processes of the depicted stage
3 neurons (from the proximal to the distal
end of the process) by ratio imaging against
the cytoplasmic volume. The data shown
are representative of more than 40 stage 2
neurons.
(B) Percentage of polarized neurons ectopi-
cally expressing wt Op18, Op18-S16A mu-
tant, or a control vector. Op18-S16A induces
more severe polarity defects than wt Op18
(*p < 0.001 between Op18-S16A and vector,
whereas p = 0.1 between wt Op18 and
vector, c2 test; n = 115 neurons for control
vector, 112 for Op18-S16A, and 107 for
wt Op18).
(C) Op18-S16A inhibits the formation of multi-
ple axons induced upon DOCK7 expression.
Percentage of neurons with more that one
axon is shown. (*p < 0.001, c2 test; n = 55 neu-
rons for each condition).
Error bars in (B) and (C) indicate SEM.as has been reported for nonneuronal cells (Gavet et al.,
1998). Whereas most of the control vector transfected
neurons acquired normal polarity, we observed that ex-
pression of the wt Op18 construct somewhat reduced
the number of polarized cells. However, this effect was
moderate compared to cells expressing the Op18-
S16A mutant (Figure 7B), where a significant number
of Op18-S16A-expressing neurons lacked a long axon.
We then examined whether the Op18-S16A mutant can
suppress the DOCK7-induced formation of multiple
axons and found that this is indeed the case (Figure 7C).
The majority of neurons coexpressing DOCK7 and
Op18-S16A lacked an axon. These data imply that a sig-
nificant fraction of Op18 molecules in the wt Op18-ex-
pressing neurons are phosphorylated and thus inactive,
whereas the Op18-S16A molecules in Op18-S16A-ex-
pressing neurons cannot be phosphorylated and are
always active. Hence, our findings suggest that the level
of phosphorylated Op18-S16 downstream of DOCK7
activation is important for the development of the axon.
We propose a model in which local DOCK7 activation
causes an increase in Rac activity that triggers the phos-
phorylation and inactivation of Op18 in the nascent
axon, thereby regulating MT dynamics/assembly and
contributing to the elongation of the future axon. The ki-
nase that mediates phosphorylation of Op18 down-
stream of Rac remains to be defined. In nonneuronal
cells, the p21-activating kinase (PAK) was reported to
be necessary but not sufficient for Rac-mediated Op18
phosphorylation and promotion of MT growth (Wittmann
et al., 2004). We found that interfering with PAK function(by expression of the PAK-autoinhibitory domain, AID-
PAK) does not prevent axon formation nor DOCK7-
induced multiple axon formation, suggesting the in-
volvement of other kinases in neuronal cells (Figure S5).
Consistent with our findings, Drosophila Rac has been
shown to control axon development through down-
stream effectors distinct from PAK (Ng et al., 2002;
Kim et al., 2003).
Discussion
Key events underlying axon development and neuronal
polarization involve changes in both the actin and MT
networks in the nascent axon. Recent studies have sug-
gested that localized activation of a Rac-mediated path-
way plays an important role in axon formation by con-
trolling the actin cytoskeleton (Da Silva et al., 2005;
Nishimura et al., 2005). In this report, we delineate a
distinct pathway in which local activation of the GEF,
DOCK7, regulates Rac activity to inactivate the MT-de-
stabilizing protein stathmin/Op18 (Op18) and promote
axon formation and neuronal polarization.
We identified DOCK7 as a putative activator of Rac
GTPases in a YTH screen. DOCK7 belongs to an evolu-
tionarily conserved protein superfamily with homology
to DOCK180 that is comprised of at least 11 mammalian
members, DOCK1 (DOCK180)–DOCK11 (Cote et al.,
2005; Meller et al., 2005). DOCK180, DOCK2, and
DOCK3 (MOCA) have been shown to act as GEFs for
Rac, whereas DOCK9 (Zizimin1) has been found to func-
tion as a GEF for Cdc42 (Brugnera et al., 2002; Fukui
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Namekata et al., 2004). These proteins have been impli-
cated in actin remodeling and processes such as cell mi-
gration, cell-substratum adhesion, and apoptotic-cell
engulfment. It is particularly interesting that DOCK180
and DOCK2 are involved in the directional migration of
nonneuronal cells, a process that requires cell polariza-
tion, and that DOCK2 is involved in the regulation of T
cell receptor polarization (Cote et al., 2005; Fukui et al.,
2001; Gumienny et al., 2001; Sanui et al., 2003). Up until
now, nothing was known about the function of DOCK7.
Our results demonstrate that DOCK7 associates with
and activates Rac, but not Cdc42 or RhoA GTPases,
and that DOCK7 is highly expressed in the developing
brain. Most importantly, our data unveil a critical role
for DOCK7 as a Rac-GEF in the early stage of axon for-
mation. First, we show that DOCK7 is enriched in a single
neurite of stage 2 hippocampal neurons and that it is se-
lectively expressed in the axon of polarized stage 3 neu-
rons, suggesting the involvement of DOCK7 in priming
one neurite to become the axon. Second, ectopic ex-
pression of DOCK7 (but not DOCK7DDHR-2) in hippo-
campal neurons induces the formation of multiple
axons, which can be suppressed by coexpression of
dominant-negative mutant forms of Rac GTPases. Fi-
nally, we demonstrate that knockdown of DOCK7 in
E18 hippocampal neurons prevents the formation of an
axon. These results indicate that DOCK7 is required
for axon formation and that other endogenously ex-
pressed DOCK180 family members cannot compensate
for the lack of its function. Thus, our findings demon-
strate a crucial role for DOCK7 in neuronal polarization
and raise the possibility that DOCK180 family members
function in general as key regulators of polarization in
different types of cells.
A number of studies support the idea that, in addition
to a dramatic influx of MTs into the nascent axon, dy-
namic reorganization of the MT network is important
for axonal differentiation (Baas, 2002; Dent and Gertler,
2003; Yu et al., 2001). However, the behavior of MTs
and the molecular mechanisms regulating the MT net-
work during early steps of axon formation remain largely
elusive. Here we present data showing that DOCK7 and
Rac control the phosphorylation of the MT-destabilizing
protein Op18 on serine 16 in developing hippocampal
neurons, with loss of either DOCK7 or Rac function
significantly decreasing the levels of laminin-induced
Op18-S16-P. While Op18 can be phosphorylated on up
to 4 residues in response to extracellular stimuli or dur-
ing mitosis, the phosphorylation of Op18 specifically at
serine 16 by activated Rac is sufficient to inactivate its
MT-destabilizing activities (Curmi et al., 1999; Daub
et al., 2001; Rubin and Atweh, 2004; Wittmann et al.,
2004). Based on these findings and our observations
that DOCK7 is concentrated in just one neurite of stage
2 neurons and is selectively expressed in the axon, we
infer that DOCK7 locally triggers Op18-S16 phosphory-
lation through Rac activation to inactivate its MT-desta-
bilizing capabilities in the nascent axon. Importantly, we
also found that levels of Op18-S16-P (but not total Op18)
are higher in the nearly formed axon than in the future
dendrites and that expression of a phosphorylation-
deficient Op18-S16A mutant significantly perturbs neu-
ronal polarity, whereas wt Op18 does so only slightly,suggesting that local Op18-S16 phosphorylation is
important for axon development. Moreover, we found
that the Op18-S16A mutant blocks DOCK7-induced
multiple axon formation. Thus, our data link local regula-
tion of Op18 phosphorylation to axon development and
implicate DOCK7 and Rac as critical regulators of this
event. It is noteworthy that precedence for the impor-
tance of spatio-temporal regulation of Op18 phosphory-
lation comes from studies of mitotic and motile cells. In
mitotic cells, local phosphorylation of Op18 has been
shown to be required for mitotic spindle assembly (Niet-
hammer et al., 2004; Rubin and Atweh, 2004). In motile
cells, this event correlates with the formation of a leading
edge (Niethammer et al., 2004).
Why would a developing neuron need an MT-destabi-
lizing protein, and when and where would that neuron
need to silence its activity? Evidence from mitotic cells
indicates that the MT-destabilizing activity of Op18 is lo-
cally switched off by phosphorylation around chromo-
somes at the onset of mitosis, allowing MT polymeriza-
tion and assembly of the mitotic spindle (Niethammer
et al., 2004; Rubin and Atweh, 2004). Since early stage
hippocampal neurons express high levels of Op18,
which is distributed throughout the cell, timed and local
phosphorylation and inactivation of Op18 in the future
axon may be important to suppress MT shrinkage and
thus promote MT growth to facilitate fast elongation of
the neurite/axon. With regards to enhanced MT growth
in the developing axon, an EM study has shown that
the length of an individual MT filament is longer in the de-
veloping axon than in the minor neurites (Yu and Baas,
1994). It is therefore possible that the DOCK7-induced
local inhibition of Op18 activity contributes to increased
MT growth in the nascent axon and thereby facilitates
and/or promotes axon formation. In support of a promi-
nent role for Op18 in the development of neurons,
knockdown of Op18 expression in Drosophila (which
has a single Op18-related gene) results in neuronal
migration and differentiation defects in the central and
peripheral nervous system, including abnormalities in
neurite/axon elongation (Ozon et al., 2002). The lack of
major developmental defects in Op18 knockout mice,
however, is likely to reflect functional redundancy
among the stathmin family members, including Op18,
SCG10, SCLIP, and RB3 (Schubart et al., 1996).
DOCK7 may therefore influence the phosphorylation
and activity of these molecules as well, since the serine
16 phosphorylation site is conserved among all mem-
bers (Curmi et al., 1999).
Our data support a model in which DOCK7 regulates
MT stability in the nascent axon through Rac activation
and consequently Op18 inactivation. However, regula-
tion of MT network formation in the developing axon is
a complex process that surely involves additional mo-
lecular players. For instance, a number of signaling mol-
ecules, such as GSK-3b and the PAR complex, which
are abundantly expressed in the axon, have been linked
to MT-binding proteins that regulate MT bundling,
assembly, and/or stabilization (MAP1b, Tau, CRMP-2,
and APC) and have been shown to play a role in axon for-
mation and/or outgrowth (Jiang et al., 2005; Kishi et al.,
2005; Shi et al., 2003; Yoshimura et al., 2005; Zhou et al.,
2004). We explored the possibility that DOCK7, through
Rac activation, regulates the activity of GSK3-b.
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GSK3-b at Ser 9 inhibits its activity and that this event
is important for axon formation (Jiang et al., 2005; Yosh-
imura et al., 2005). We found, however, that knockdown
of DOCK7 did not affect GSK-3b phosphorylation at Ser
9 (Figure S6), implying that DOCK7 is not likely to influ-
ence axon formation by inhibiting GSK3-b activity
through Ser 9 phosphorylation. In the future, it will be im-
portant to determine how all of these signaling pathways
and mechanisms are integrated to mediate the develop-
ment and growth of the axon. One plausible scenario is
that local activation of DOCK7 in the future axon initiates
MT growth through the phosphorylation and inactivation
of Op18 molecules, while other protein complexes, in-
cluding some of those mentioned above, enhance
and/or sustain this growth by promoting MT stabiliza-
tion. It is important to note that DOCK7-triggered MT
growth may feed back on the actin cytoskeleton, given
that growth of MTs has been reported to trigger actin re-
modeling in fibroblasts (Waterman-Storer et al., 1999).
Although we did not see major effects on the actin net-
work, these observations do not exclude the possibility
that DOCK7 affects actin dynamics.
How DOCK7 becomes concentrated in just one neu-
rite of stage 2 neurons and is selectively expressed in
the axon, but not the dendrites, is presently unknown.
Presumably, this will involve directional protein trans-
port in response to an extracellular cue. Of interest is
our observation that DOCK7 accumulates at the basal
side of the cell where the cell attaches the substrate.
This localization pattern suggests a potential relation-
ship between DOCK7 and extracellular matrix mole-
cules, particularly between DOCK7 and laminin, which
is known to influence and promote axon development
(Esch et al., 1999). In support of this, we observed
a less severe polarity phenotype when hippocampal
neurons ectopically expressing DOCK7 were plated on
poly-L-lysine alone rather than on poly-L-lysine with
laminin (data not shown). Moreover, we found that the
S16-phosphorylation levels of Op18 are higher in neu-
rons plated on dishes coated with laminin. How laminin
influences the localization and/or activity of DOCK7 re-
mains to be addressed. With regard to this, laminin
has been shown to induce the production of
PtdIns(3,4,5)P3 in the developing axon, and DOCK180
becomes translocated to the plasma membrane of non-
neuronal cells via direct binding of its DHR-1 domain,
which is conserved in DOCK7, to PI 3-kinase generated
PtdIns(3,4,5)P3 (Cote et al., 2005; Menager et al., 2004).
Interestingly, we observed that inhibitors of PI 3-kinase
abrogated the ability of DOCK7 to induce multiple axons
(Figure S7), which is consistent with a model in which PI
3-kinase-induced PtdIns(3,4,5)P3 production is impor-
tant for DOCK7 function in axon development. Further
experiments, however, will be needed to substantiate
this model.
In summary, our findings not only offer insight into the
function of the GEF DOCK7, showing that DOCK7 acti-
vates Rac GTPases and is critically involved in axon de-
velopment, but also shed light on the regulation of MT
networks as they pertain to the early steps of axon for-
mation. Our data link DOCK7, which is asymmetrically
distributed in stage 2 unpolarized neurons, and Rac ac-
tivation to the local inactivation of the MT-destabilizingprotein Op18. They further highlight the contribution of
MT network regulation to the development of the axon
by demonstrating a role for Op18 inactivation in this pro-
cess. The identification of additional DOCK7-interacting
proteins and elucidation of cross-talk with other MT reg-
ulatory pathways is necessary to fully decipher how the
MT network is regulated to bring about neuronal polari-
zation. Future studies involving real-time imaging of MT
dynamics and growth during axon formation are also re-
quired to further reveal the contribution of these MT be-
haviors to this important developmental process in vivo.
Experimental Procedures
Yeast Two-Hybrid Screening
13 106 clones of a human fetal brain cDNA library in the pACT2 vec-
tor (Clontech) were screened using Rac1N17 cloned into pBMT116
as bait in the L40 yeast reporter strain (Van Aelst, 1998).
DNA Constructs
Full-length human DOCK7 cDNA was obtained by PCR from a human
Ntera2D1 cDNA library (gift from J. Skowronski) using 50-TTTTGAGC
TCCATGGCCGAGC GCCGCGCCTTCGCCCA-30 and 50-TTTTGGTA
CCAAGCGTTAACAATCTACATTTGATA TTTTC-30 primers (Gen-
Bank accession: DQ341187). The DOCK7 cDNA was then cloned
into various expression vectors (see Supplemental Data for all
constructs).
DOCK7 Antibody
The anti-DOCK7 antibody was raised in rabbits against a peptide
corresponding to amino acids 132–151 of human DOCK7, which is
conserved in the mouse and rat DOCK7 protein.
Cell Culture, Transfection, and Infection
HEK293, HEK293T, and N1E-115 neuroblastoma cells were cultured
in DMEM containing 10% fetal bovine serum. HEK293 and HEK293T
cells were transfected using a calcium phosphate method. Primary
hippocampal neuron cultures were prepared from E18 rat embryos
as described (Pak et al., 2001). The dissociated neurons were
seeded on coverslips or dishes coated with a mixture of poly-L-ly-
sine (40 mg/ml) and laminin (2.5 mg/ml) prepared in water. To assess
the effect of laminin, neurons were plated on dishes first coated with
poly-L-lysine (1 mg/ml) in borate buffer (pH 8.5) and then layered
with 10 mg/ml laminin in PBS. Transfection of neurons was carried
out immediately after dissociation using the Amaxa Nucleofector
device (Amaxa GmbH). Three micrograms total of the indicated plas-
mids and 0.02 mg of pCAGGS-GFP were used per electroporation.
Neurons were infected with lentiviruses or adenoviruses 3 hr after
plating (see Supplemental Data).
Immunofluorescence and Imaging
Parasagittal frozen brain sections (10 mm) from P2 rats and dissoci-
ated hippocampal neurons were fixed with 3.5% paraformaldehyde,
permeabilized with 0.2% Triton X-100 in PBS, and stained with indi-
cated antibodies (see Supplemental Data). Images were acquired
using an Axiovert 100M confocal laser scanning microscope (Zeiss)
with a 633/1.40 Plan-Apochromat objective or an Axioskop 2 plus
fluorescence microscope (Zeiss) with a 403/0.75 Plan-Neofluor ob-
jective. Data analysis is described in Supplemental Data.
Other Procedures
The methods for GST pull-down assays, coimmunoprecipitations,
and guanine nucleotide exchange assays are described in Supple-
mental Data.
Supplemental Data
The Supplemental Data for this article include Supplemental Exper-
imental Procedures and seven figures and can be found online at
http://www.neuron.org/cgi/content/full/51/6/727/DC1/.
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